Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.

ABSTRACT:

Background

The TREAT Registry Taskforce is a collaborative effort of international registries aiming to provide real-world data on the long-term efficacy, cost-effectiveness and safety of systemic treatments and phototherapy for atopic eczema (AE).

Objectives

This study seeks to present a comprehensive overview of the demographics, prior systemic treatments, clinical characteristics and disease severity and burden at baseline among patients enrolled in seven TREAT registries. Moreover, the aim is to gain insight into the differences between the registries and to explore the current prescribing practices of various therapies for patients with AE across Europe.

Methods

Data from June 2016 to 31 October 2022, were collected from seven observational cohorts: A-STAR (UK/Ir

SUBMITTER: Musters AH 

PROVIDER: S-EPMC12645184 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature